Concepedia

David Frederick

DF

Statistics

Publications

24

Citations

1.6K

H-Index

19

Active since

1986

Affiliations

National Center for Toxicological Research(Current)

Gilead Sciences (United States)

Hôpital Beaujon

University of Arkansas for Medical Sciences

Inserm

David Frederick is an author at National Center for Toxicological Research specializing in pharmacology, adefovir dipivoxil therapy, and antiviral therapy.

Publications per year

1986–2012

24

Publications

24

Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, and entecavir in patients with decompensated chronic hepatitis B liver disease

Yun‐Fan Liaw, I‐Shyan Sheen, Chuan–Mo Lee et al. · Hepatology · 2010 · 323 citations

, , +17

Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B

Patrick Marcellin, Ting‐Tsung Chang, Seng Gee Lim et al. · Hepatology · 2008 · 310 citations

, , +17

Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus Infection

Thomas Berg, Patrick Marcellin, Fabien Zoulim et al. · Gastroenterology · 2010 · 143 citations · Full text

, , +15

Safety, efficacy, and pharmacokinetics of adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B

Maureen M. Jonas, Déirdre Kelly, Henry Pollack et al. · Hepatology · 2008 · 122 citations · Full text

, , +17

Corticosteroids in COPD

Orn Eliasson, Joseph G. Hoffman, Dianne Trueb et al. · CHEST Journal · 1986 · 79 citations

1–5 of 24